Sort
39,280 grants matching “leukemia”
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
$1,091,666David L Lampi Hermanson · B-Mogen Biotechnologies, Inc. · R44 · FY2019 · CA
MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION IN HUMAN LEUKEMIA
$1,091,590Paul Liu · National Human Genome Research Institute · ZIA · FY2011 · HG
Molecular-Cellular Regulation of Hematopoietic Stem Cells
$1,091,585Jonathan R Keller · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
$1,090,808Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R35 · FY2025 · HL
NHGRI/DIR Cytogenetics and Microscopy Core
$1,090,671Leslie Biesecker · National Human Genome Research Institute · ZIC · FY2010 · HG
Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy
$1,090,503Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Bone Marrow Failure Clinical Research Center
$1,089,924Cleveland Clinic Lerner Col/Med-Cwru · U54 · FY2004 · RR
Hematopathology Diagnosis
$1,088,717Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Tissue Culture Laboratory
$1,087,580Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2010 · HL
Clinical Trials with Immunotoxins
$1,086,638Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Cancer and Leukemia Group B Human Specimen Repositories
$1,086,261Monica M Bertagnolli · Brigham And Women'S Hospital · U24 · FY2013 · CA
CH in Aging and Exceptional Longevity
$1,085,789Aditi Shastri · Albert Einstein College Of Medicine · R01 · FY2024 · AG
ONCOGENES IN CANCER ETIOLOGY AND PROGRESSION
$1,085,565Thomas Jefferson University · P01 · FY2001 · CA
Bio-Therapies for the Treatment of Cancer
$1,085,439David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,084,624Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Genomics of Acute myelogenous leukemia (AML): Whole Genome Resequencing
$1,084,162Richard K. Wilson · Washington University · P01 · FY2011 · CA
TARGETING PCD FOR CANCER THERAPY
$1,084,031University Of Michigan At Ann Arbor · P01 · FY2002 · CA
Growth Regulation and Therapy of Leukemias and Lymphomas
$1,083,899University Of Kentucky · P01 · FY2003 · CA
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,083,717Claire F Verschraegen · Ohio State University · UG1 · FY2022 · CA
Blood Genomics Approach for Neuropsychiatric Disorders
$1,083,243Daniel Weinberger · National Institute Of Mental Health · ZIA · FY2009 · MH
MOUSE MODELS OF MYELOID LEUKEMIA
$1,082,737University Of California San Francisco · U01 · FY2002 · CA
Molecular-Cellular Regulation of Hematopoietic Stem Cells
$1,082,718Jonathan R Keller · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Chromatin and epigenetic memory
$1,082,350Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
NHGRI/DIR Zebrafish Core
$1,081,993Raman Sood · National Human Genome Research Institute · ZIC · FY2019 · HG
Molecular Mechanisms of HTLV-1 Infection and Replication
$1,081,407David Derse · Basic Sciences · Z01 · FY2007 · CA